Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Gene Therapy

Deerfield Licenses Gene Therapy from University College London Business & Apollo Therapeutics Collaborative

Drug development deals become more complex and intriguing by the month as University College London Business (UCLB) and Apollo Therapeutics […]

Deerfield Licenses Gene Therapy from University College London Business & Apollo Therapeutics Collaborative
8 months ago
Share

Mass Eye & Ear & MGH Select Novartis’ AveXis as Manufacturer for Gene Therapy-based COVID-19 Vaccine in Preclinical Stage

The AAVCOVID vaccine program at Massachusetts Eye and Ear and Massachusetts General Hospital, member of Mass General Bingham, has entered into […]

Mass Eye & Ear & MGH Select Novartis’ AveXis as Manufacturer for Gene Therapy-based COVID-19 Vaccine in Preclinical Stage
9 months ago
Share

Global Demand for Cell & Gene Therapy Treatments Drive Major Expansions in Production for Thermo Fisher Scientific

With rapid growth of cell and gene therapy development comes shortages and bottlenecks the require specialized manufacturing capability associated with […]

Global Demand for Cell & Gene Therapy Treatments Drive Major Expansions in Production for Thermo Fisher Scientific
10 months ago
Share

UT Southwestern Spinoff Comes out of Stealth Mode with a $30 Million Seed Round for Gene Therapy Platform

Taysha Gene Therapies just emerged out of stealth mode with a $30 million seed round and a strategic partnership with UT […]

UT Southwestern Spinoff Comes out of Stealth Mode with a $30 Million Seed Round for Gene Therapy Platform
10 months ago
Share

Sofinnova Partners’ Italian Rare & Gene Therapy Disease Fund Places Third Bet in Italian Gene Therapy Startup

Paris-based Sofinnova Partners placed a bet in Milan-based Genespire, a gene-therapy company developing best-in-class therapies for patients affected by gene disease. The […]

Sofinnova Partners’ Italian Rare & Gene Therapy Disease Fund Places Third Bet in Italian Gene Therapy Startup
11 months ago
Share

Princeton Neuroscience Institute Develops System to Switch Genes on: Seek Business Partnership

Esteban Engel, a viral neuroengineering researcher with Princeton Neuroscience Institute and team have developed a system for switching on the […]

Princeton Neuroscience Institute Develops System to Switch Genes on: Seek Business Partnership
11 months ago
Share

Elite Research Centers Ink Deal with Lonza to Evaluate (Pilot) Cell Therapy Manufacturing for Next Generation Treatments

In a notable partnership, Switzerland-based Lonza inked a partnership with leading research institutes and academic medical centers including Stanford University […]

Elite Research Centers Ink Deal with Lonza to Evaluate (Pilot) Cell Therapy Manufacturing for Next Generation Treatments
12 months ago
Share

Nationwide Children’s Hospital Submits Proposal to HHS to use Genetically Engineered NK Cells Targeting COVID-19

Nationwide Children’s Hospital (NCH), a global hub for advanced gene therapy discovery, has submitted a proposal to the Biomedical Advanced […]

Nationwide Children’s Hospital Submits Proposal to HHS to use Genetically Engineered NK Cells Targeting COVID-19
12 months ago
Share

Boston’s Cure Rare Disease on the Cusp of CRISPR-based Personalized Treatment for type of Duchenne Muscular Dystrophy

In a compelling story of brotherly love, familial connection, and the power of entrepreneurial energies, a 28-year old Boston-based entrepreneur, […]

Boston’s Cure Rare Disease on the Cusp of CRISPR-based Personalized Treatment for type of Duchenne Muscular Dystrophy
12 months ago
Share

Prevail Therapeutics Receives IND Approval for Gene Therapy in Patients with Frontotemporal Dementia with GRN Mutation

Prevail Therapeutics announced that the U.S. FDA has approved an Investigational New Drug (IND) application for its experimental gene therapy […]

Prevail Therapeutics Receives IND Approval for Gene Therapy in Patients with Frontotemporal Dementia with GRN Mutation
1 year ago
Share

Posts navigation

Older posts
Newer posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.